Pages that link to "Q37084865"

The following pages link to Ethnic diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of heroin addicts (Q37084865):

Displaying 33 items.

• The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review (Q24616528) (← links)
• Current and Future Prospects for Epigenetic Biomarkers of Substance Use Disorders (Q26782279) (← links)
• Telomeres and epigenetics: potential relevance to chronic pain (Q27001692) (← links)
• Identification of genetic and epigenetic marks involved in population structure (Q33719361) (← links)
• Accounting for population stratification in DNA methylation studies. (Q33874933) (← links)
• Identification of methylation quantitative trait loci (mQTLs) influencing promoter DNA methylation of alcohol dependence risk genes (Q34022716) (← links)
• Novel pharmacotherapeutic strategies for treatment of opioid-induced neonatal abstinence syndrome (Q34081859) (← links)
• Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome (Q34090556) (← links)
• Forced Abstinence from Cocaine Self-Administration is Associated with DNA Methylation Changes in Myelin Genes in the Corpus Callosum: a Preliminary Study (Q36031125) (← links)
• Epigenetics of drug abuse: predisposition or response (Q36295032) (← links)
• The MTHFR C677T Variant is Associated with Responsiveness to Disulfiram Treatment for Cocaine Dependency (Q36529100) (← links)
• Ethnicity interacts with the OPRM1 gene in experimental pain sensitivity. (Q36932009) (← links)
• A Framework to Examine the Role of Epigenetics in Health Disparities among Native Americans (Q37413020) (← links)
• Endogenous opiates and behavior: 2010 (Q37943604) (← links)
• Epigenetics of µ-opioid receptors: intersection with HIV-1 infection of the central nervous system (Q37950301) (← links)
• The epigenetic side of human adaptation: hypotheses, evidences and theories (Q38270060) (← links)
• Therapies in early development for the treatment of opiate addiction (Q38594606) (← links)
• Pharmacoepigenomics of opiates and methadone maintenance treatment: current data and perspectives (Q38608450) (← links)
• Epigenome-wide association of PTSD from heterogeneous cohorts with a common multi-site analysis pipeline (Q38686747) (← links)
• DNA methylation-based variation between human populations (Q38798399) (← links)
• Review: DNA methylation and alcohol use disorders: Progress and challenges (Q38809006) (← links)
• Elevated levels of DNA methylation at the OPRM1 promoter in blood and sperm from male opioid addicts (Q42119923) (← links)
• The genetic epidemiology of substance use disorder: A review (Q43075979) (← links)
• Gender Interacts with Opioid Receptor Polymorphism A118G and Serotonin Receptor Polymorphism -1438 A/G on Speed-Dating Success (Q44337200) (← links)
• Elevated levels of DNA methylation at the OPRM1 promoter region in men with opioid use disorder. (Q44342878) (← links)
• OPRM1 Methylation Contributes to Opioid Tolerance in Cancer Patients (Q44345268) (← links)
• From forensic epigenetics to forensic epigenomics: broadening DNA investigative intelligence. (Q47169792) (← links)
• Sex and litter effects on anxiety and DNA methylation levels of stress and neurotrophin genes in adolescent rats (Q48139635) (← links)
• Variability of response to methadone: genome-wide DNA methylation analysis in two independent cohorts. (Q52308504) (← links)
• Biochemical Diagnosis in Substance and Non-substance Addiction. (Q52314530) (← links)
• Genomewide Study of Epigenetic Biomarkers of Opioid Dependence in European- American Women (Q64090991) (← links)
• Exposure to environmental enrichment attenuates addiction-like behavior and alters molecular effects of heroin self-administration in rats (Q89379804) (← links)
• Racial association and pharmacotherapy in neonatal opioid withdrawal syndrome (Q92461072) (← links)